Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
November 13, 2025Frontiers in PharmacologyOpen Access

Myasthenia gravis and community-acquired pneumonia: therapeutic challenges

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXueying ChenJDJian-bo DingJZJiali Zhang

Discussion

Loading...

Member takes

Overview

Review reveals therapeutic challenges in managing pneumonia alongside myasthenia gravis, highlighting critical care strategies.

Key Points

  • To address the pharmacotherapeutic challenges in patients with myasthenia gravis and community-acquired pneumonia.
  • Synthesize literature on MG-CAP comorbidity
  • Focus on antibiotics that do not worsen neuromuscular symptoms
  • Discuss management of immunosuppressants based on infection severity
  • Identified key challenges in antibiotic selection and drug interactions
  • Provided recommendations for optimizing treatment in MG-CAP patients
  • Emphasized the need for patient-centered approaches in clinical decision-making

Cite This Study

Chen et al. (2025) studied this question.

synapsesocial.com/papers/692523b2c0ce034ddc354896https://doi.org/10.3389/fphar.2025.1695526
View Full Paper
Ask AI
Bookmark
Share